TITLE

Peripheral Immune Cell Gene Expression Changes in Advanced Non-Small Cell Lung Cancer Patients Treated with First Line Combination Chemotherapy

AUTHOR(S)
Chen, Yung-Che; Hsiao, Chang-Chun; Chen, Kuang-Den; Hung, Yu-Chiang; Wu, Ching-Yuan; Lie, Chien-Hao; Liu, Shih-Feng; Sung, Ming-Tse; Chen, Chung-Jen; Wang, Ting-Ya; Chang, Jen-Chieh; Tang, Petrus; Fang, Wen-Feng; Wang, Yi-Hsi; Chung, Yu-Hsiu; Chao, Tung-Ying; Leung, Sum-Yee; Su, Mao-Chang; Wang, Chin-Chou; Lin, Meng-Chih
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Increasing evidence has shown that immune surveillance is compromised in a tumor-promoting microenvironment for patients with non-small cell lung cancer (NSCLC), and can be restored by appropriate chemotherapy. Methods: To test this hypothesis, we analyzed microarray gene expression profiles of peripheral blood mononuclear cells from 30 patients with newly-diagnosed advanced stage NSCLC, and 20 age-, sex-, and co-morbidity-matched healthy controls. All the patients received a median of four courses of chemotherapy with cisplatin and gemcitabine for a 28-day cycle as first line treatment. Results: Sixty-nine differentially expressed genes between the patients and controls, and 59 differentially expressed genes before and after chemotherapy were identified. The IL4 pathway was significantly enriched in both tumor progression and chemotherapy signatures. CXCR4 and IL2RG were down-regulated, while DOK2 and S100A15 were up-regulated in the patients, and expressions of all four genes were partially or totally reversed after chemotherapy. Real-time quantitative RT-PCR for the four up-regulated (S100A15, DOK2) and down-regulated (TLR7, TOP1MT) genes in the patients, and the six up-regulated (TLR7, CRISP3, TOP1MT) and down-regulated (S100A15, DOK2, IL2RG) genes after chemotherapy confirmed the validity of the microarray results. Further immunohistochemical analysis of the paraffin-embedded lung cancer tissues identified strong S100A15 nuclear staining not only in stage IV NSCLC as compared to stage IIIB NSCLC (p = 0.005), but also in patients with stable or progressive disease as compared to those with a partial response (p = 0.032). A high percentage of S100A15 nuclear stained cells (HR 1.028, p = 0.01) was the only independent factor associated with three-year overall mortality. Conclusions: Our results suggest a potential role of the IL4 pathway in immune surveillance of advanced stage NSCLC, and immune potentiation of combination chemotherapy. S100A15 may serve as a potential biomarker for tumor staging, and a predictor of poor prognosis in NSCLC.
ACCESSION #
87625163

 

Related Articles

  • Gene Expression Significance in Personalized Medicine of Non-small Cell Lung Cancer and Gene Expression Analyzing Platforms. Li Zhang; Huiyi Yang; Jiasen Xu // Current Drug Metabolism;Jun2011, Vol. 12 Issue 5, p455 

    No abstract available.

  • Gene Expression Significance in Personalized Medicine of Non-small Cell Lung Cancer and Gene Expression Analyzing Platforms. Li Zhang; Huiyi Yang; Jiasen Xu // Current Drug Metabolism;Jun2011, Vol. 12 Issue 5, p455 

    No abstract available.

  • Expression of Adiponectin Receptor 1 Is Indicative of Favorable Prognosis in Non-small Cell Lung Carcinoma. Abdul-Ghafar, Jamshid; Sung Soo Oh; Park, Sun-Mi; Wairagu, Peninah; Shun Nyung Lee; Yangsik Jeong; Minseob Eom; Suk-Joong Yong; Soon-Hee Jung // Tohoku Journal of Experimental Medicine;Feb2013, Vol. 229 Issue 2, p153 

    Lung cancer is a major cause of cancer-related death worldwide. It is believed that obesity-related malignancies such as breast, endometrial, colorectal, and kidney carcinomas have lower plasma level and/ or tissue expression of adiponectin receptors. However, the association between adiponectin...

  • Expression of THOP1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer. Qi, Lei; Li, Shu-hai; Si, Li-bo; Lu, Ming; Tian, Hui // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Background: The study was designed to detect the expression level of thimet oligopeptidase (THOP1) protein in non-small cell lung cancer (NSCLC) and investigate its correlation with clinicopathologic features and prognosis. Methods: Immunohistochemical staining was used to determine the...

  • ROLE OF PROGRANULIN GENE EXPRESSION AS A MOLECULAR BIOMARKER FOR BLADDER CANCER. El-khair, Salwa M. Abo; Mohamed, Mie A.; Alkhiary, Tamer E. // American Journal of Biochemistry & Biotechnology;2012, Vol. 8 Issue 2, p71 

    Bladder cancer is the second most common cancer of the urinary system. Early diagnosis of this tumor and estimation of risk of future progression has a significant impact on prognosis. Although there are several molecular markers for the diagnosis and prognosis for this tumor, their accuracy is...

  • Expression of seven stem-cell-associated markers in human airway biopsy specimens obtained via fiberoptic bronchoscopy. Laodong Li; Huina Yu; Xiaoyang Wang; Jinrong Zeng; Dangyu Li; Jingyan Lu; Changming Wang; Jiying Wang; Jianghong Wei; Ming Jiang; Biwen Mo // Journal of Experimental & Clinical Cancer Research (17569966);2013, Vol. 32 Issue 1, p1 

    Background: Previous reports have suggested that malignant transformations originate from adult stem cells, and may thus express the stem-cell-associated markers. The purpose of this study is to investigate the differential expression and clinical significance of seven stem-cell-associated...

  • Prohibitin: a potential biomarker for tissue-based detection of gastric cancer. Xiandong Kang; Long Zhang; Jian Sun; Zhenhua Ni; Yanchun Ma; Xiaobo Chen; Xia Sheng; Teng Chen // Journal of Gastroenterology;2008, Vol. 43 Issue 8, p618 

    Prohibitin (PHB) was found to be overexpressed in breast cancer and thus is suggested as a biomarker in that disease. A few studies have investigated the PHB expression pattern in gastric cancer by two-dimensional gel electrophoresis. Uncertainties still existed on whether PHB expression could...

  • S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer. Li-Yong Huang; Ye Xu; Guo-Xiang Cai; Zu-Qing Guan; Wei-Qi Sheng; Hong-Fen Lu; Li-Qi Xie; Hao-Jie Lu; San-Jun Cai // Annals of Gastroenterology & Hepatology;2011, Vol. 9 Issue 92, p69 

    AIM: To develop lymph node metastasis (LNM)-associated biomarkers for colorectal cancer (CRC) using quantitative proteome analysis. METHODS: Differences in protein expression between primary CRC with LNM (LNM CRC) and without LNM (non-LNM CRC) were assessed using methyl esterification stable...

  • Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer. Varambally, Sooryanarayana; Laxman, Bharathi; Mehra, Rohit; Qi Cao; Dhanasekaran, Saravana M.; Tomlins, Scott A.; Granger, Jill; Vellaichamy, Adaikkalam; Sreekumar, Arun; Jianjun Yu; Wenjuan Gu; Ronglai Shen; Ghosh, Debashis; Wright, Lorinda M.; Kladney, Raleigh D.; Kuefer, Rainer; Rubin, Mark A.; Fimmel, Claus J.; Chinnaiyan, Arul M. // Neoplasia;Nov2008, Vol. 10 Issue 11, p1285 

    Prostate cancer is the most common type of tumor found in American men and is the second leading cause of cancer death in males. To identify biomarkers that distinguish prostate cancer from normal, we compared multiple gene expression profiling studies. Through meta-analysis of expression array...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics